Researchers examined patients with Barrett’s esophagus and followed up for a mean of 5.52 years for the study, titled “Patients With Nondysplastic Barrett’s Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma.”
The authors found a 0.27 percent incidence of EAC and a 0.48 percent incidence of high-grade dysplasia among the patients. Furthermore, five years after diagnosis, 98.6 percent were cancer free, as were 97.1 percent 10 years after diagnosis.
These results show a lower incidence of dysplasia and EAC among patients with NDBE than previously reported. The authors suggest surveillance intervals for patients could be lengthened.
Read the Clinical Gastroenterology and Hepatology abstract on Barrett’s Esophagus.
Read more coverage on GI issues:
– Esophageal Cancer Diagnosis Increasing Faster Than Other Cancer Diagnoses
– Expert Cautions Findings on Pancreatic Cancer Screening
– Improperly Disinfected Endoscopes Used on Patients at Louisiana Hospital
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.